

ZIOPHARM Oncology is an American biopharmaceutical company developing novel therapeutics for the treatment of cancer. Among its major competitors, ZIOPHARM Oncology is ranked in 7th place for NPS while Illumina is 1st, and REGENXBIO is 2nd.Their current market cap is $187.12M